基于网络药理学及分子对接分析桃仁红花煎治疗心肌缺血再灌注损伤的作用机制

Abstract
Figure/Table
References (20)
Related Citation (14)

Download: PDF (1430 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To analyze the mechanism of Taoren Honghua Decoction in the treatment of myocardial ischemia reperfusion injury based on network pharmacology and molecular docking.Methods The chemical components and targets of Taoren Hongghua Decoction and MIRI targets were collected by searching the database.Cytoscape 3.8.2 was used to make active components-target network diagram and protein interaction network diagram of Taoren Honghua Decoction.DAVID database was used to conduct gene ontology (GO) enrichment analysis and Kyoto encyclopedia of genes and genomes (KEGG) signaling pathway analysis on the related target.PyMol 2.5.2 and AutoDockTools 1.5.6 software were used for molecular docking of core components and core targets of Taoren Honghua decoction.Results Two hundred and one active ingredients,303 potential therapeutic target genes and 86 common targets for the treatment of MIRI were finally obtained.It was predicted that the main components of Taoren Honghua Decoction in the treatment of MIRI were quercetin,β-sitosterol,luteolin, etc. The key targets were protein kinase B (AKT1),interleukin-6(IL-6),tumor necrosis factor (TNF), etc. The results of KEGG analysis suggested that the key pathways may include TNF signaling pathway and hypoxia inducible factor-1 (HIF-1) signaling pathway, etc.Molecular docking results showed that core components and targets of Taoren Honghua Decoction might have good affinities.Conclusion This study speculated that Taoren Honghua Decoction may treat MIRI through multiple components,multiple targets and multiple pathways.

Key words： Network pharmacology Molecular docking Taoren Honghua Decoction Myocardial ischemia reperfusion injury

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	HONG Qiuyu
	WU Ya′nan
	ZHAO Haoxi
	WAN Xinliang

Cite this article:

HONG Qiuyu,WU Ya′nan,ZHAO Haoxi, et al. Mechanism analysis of Taoren Honghua Decoction in the treatment of myocardial ischemia reperfusion injury based on network pharmacology and molecular docking[J]. 中国当代医药, 2022, 29(14): 14-17-31.

URL:

https://www.dangdaiyiyao.com/EN/ OR https://www.dangdaiyiyao.com/EN/Y2022/V29/I14/14

[1]	胡强，张权宇.冠状动脉功能学评价指标在经皮冠状动脉介入术中的应用进展[J].解放军医学杂志，2021，46（11）：1129-1135.
[2]	刘志远，张金盈，刘江波，等.冠脉内注射重组人尿激酶原溶栓联合PCI 对急性心肌梗死患者冠脉血流水平、无复流发生率及预后的影响[J].重庆医科大学学报，2020，45（4）：510-516.
[3]	李泽华，关贤颂，蒋路平.黄芪甲苷通过NRF2/HO-1 信号通路减轻小鼠心肌缺血再灌注损伤[J].中国病理生理杂志，2021，37（12）：2147-2153.
[4]	Li LT，Li XZ，Zhang Z，et al.Protective Mechanism and Clinical Application of Hydrogen in Myocardial Ischemiareperfusion Injury[J].Pak J Biol Sci，2020，23（2）：103-112.
[5]	谢静文，苏天德，魏雨亭，等.抗氧化药物在心肌缺血再灌注损伤中的研究进展[J].药学学报，2021，56（7）：1845-1855.
[6]	胡婷，包怡敏.益气活血法抗心肌缺血再灌注损伤的作用机制[J].中国实验方剂学杂志，2018，24（22）：228-234.
[7]	罗洋，庞建中.桃仁红花煎治疗劳力性心绞痛心血瘀阻证疗效观察[J].现代中西医结合杂志，2020，29（7）：749-752.
[8]	黎均铭.桃仁红花煎治疗缺血性心脏病56 例临床观察[J].实用中医内科杂志，2016，30（5）：36-37.
[9]	谭巨浪，胡晓军，张臻，等.桃仁红花煎联合伊伐布雷定治疗血络瘀阻型持续性房颤的临床效果[J].中国当代医药，2021，28（16）：178-183.
[10]	刘振华，张艳红，董杰，等.槲皮素通过上调SIRT1 降低心肌缺血/再灌注微血管通透性[J].中国病理生理杂志，2020，36（4）：644-651.
[11]	严宁，杨春霞，马娟，等.β-谷甾醇对大鼠心肌缺血再灌注损伤和ERK1/2 信号通路的影响[J].心血管病学进展，2020，41（3）：321-325.
[12]	樊维娜，孙经武.木犀草素预处理对心肌缺血再灌注损伤大鼠炎症反应及细胞凋亡的影响[J].陕西中医，2015，36（11）：1558-1560.
[13]	Kunuthur SP，Mocanu MM，Hemmings BA，et al.The Akt1 isoform is an essential mediator of ischaemic preconditioning[J].J Cell Mol Med，2012，16（8）：1739-1749.
[17]	Han XF，Chen X，Han JQ，et al.MiR -324/SOCS3 Axis Protects Against Hypoxia/Reoxygenation-Induced Cardiomyocyte Injury and Regulates Myocardial Ischemia via TNF/NF-κB Signaling Pathway[J].Int Heart J，2020，61（6）：1258-1269.
[18]	王文香，张妞妞，曾先燕，等.HIF-1α 抗心肌缺血再灌注炎性损伤的作用[J].中国病理生理杂志，2018，34（7）：1201-1205.
[19]	王怡茹，张一凡，韦婧，等.桃仁红花煎通过抑制淋巴管增生改善ApoE-（-/-）小鼠动脉粥样硬化的炎症反应[J].暨南大学学报（自然科学与医学版），2021，42（1）：62-70.
[20]	李巧红.桃仁红花煎抗血小板聚集及改善血液流变实验研究[J].亚太传统医药，2016，12（9）：14-15.
[14]	Chi Y，Ma Q，Ding XQ，et al.Research on protective mechanism of ibuprofen in myocardial ischemia-reperfusion injury in rats through the PI3K/Akt/mTOR signaling pathway[J].Eur Rev Med Pharmacol Sci，2019，23（10）：4465-4473.
[15]	龚燚婷，李彦萍，程亚茹，等.基于HIF-1 信号通路研究芪参益气滴丸治疗心肌缺血的分子机制[J].中国中药杂志，2021，46（15）：3949-3959.
[16]	李玲美，付建华，郭浩，等.注射用红花黄色素经TLRNF-κB 炎症通路抗大鼠MIRI 的保护作用研究[J].中国中药杂志，2019，44（12）：2566-2571.